Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1470-1476

  Ozeki, Noriyuki ^a   Hara, Kenji ^a   Yatsuka, Chikako ^a   Nakano, Tomoki ^a   Matsumoto, Sachiko ^a   Suetsugu, Mariko ^a   Nakamachi, Takafumi ^a   Takebayashi, Kohzo ^a   Inukai, Toshihiko ^a   Haruki, Kohsuke ^a   Aso, Yoshimasa ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LOADING TEST; MALE; MOLECULAR WEIGHT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; MOLECULAR WEIGHT; TRIGLYCERIDES;

EID: 70149112111     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.042     Document Type: Article

References (27)

1. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
2. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
3. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
4. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
5. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278 (2003) 9073-9085
6. Tsao T.S., Tomas E., Murrey H.E., Hug C., Lee D.H., Ruderman N.B., et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278 (2003) 50810-50817
7. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279 (2004) 12152-12162
8. Aso Y., Yamamoto R., Suetsugu M., Matsumoto S., Wakabayashi S., Matsutomo R., et al. Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with type 2 diabetes. Diabet Med 24 (2007) 962-968
9. Hoffstedt J., Arvidsson E., Sjölin E., Wåhlén K., and Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89 (2004) 1391-1396
10. Peake P.W., Kriketos A.D., Campbell L.V., Shen Y., and Charlesworth J.A. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 153 (2005) 409-417
11. Heliövaara M.K., Strandberg T.E., Karonen S.L., and Ebeling P. Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans. Horm Metab Res 38 (2006) 336-340
12. Peake P.W., Kriketos A.D., Denyer G.S., Campbell L.V., and Charlesworth J.A. The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects. Int J Obes Relat Metab Disord 27 (2003) 657-662
13. Karlsson F.A., Engström B.E., Lind L., and Ohrvall M. No postprandial increase of plasma adiponectin in obese subjects. Obes Res 12 (2004) 1031-1032
14. Tanaka A., Tomie N., Nakano T., et al. Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test. Clin Chem Acta 275 (1998) 43-52
15. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
16. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 47 (2006) 1572-1582
17. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55 (2006) 1954-1960
18. Basu R., Pajvani U.B., Rizza R.A., and Scherer P.E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56 (2007) 2174-2177
19. Yamauchi J., Osawa H., Takasuka T., Ochi M., Murakami A., Nishida W., et al. Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism 57 (2008) 149-156
20. Yu J.G., Javorschi S., Hevener A.L., Kruszynska Y.T., Norman R.A., Sinha M., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51 (2002) 2968-2974
21. Möhlig M., Wegewitz U., Osterhoff M., Isken F., Ristow M., Pfeiffer A.F., et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 34 (2002) 655-658
22. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290 (2002) 1084-1089
23. Pratley R.E., and Weyer C. The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44 (2001) 929-945
24. Wang Z.V., Schraw T.D., Kim J.Y., Khan T., Rajala M.W., Follenzi A., et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 27 (2007) 3716-3731
25. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87 (2002) 2764-2769
26. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103 (2002) 137-142
27. Wakabayashi S., and Aso Y. Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diabetes Care 27 (2004) 2392-2397